MOH — authorised 19 February 2002
- Marketing authorisation holder: SPECTRUM PHARMS
- Status: likely_approved
🇮🇱 Zevalin in Israel
MOH authorised Zevalin on 19 February 2002
Marketing authorisation
Zevalin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Zevalin approved in Israel?
Yes. MOH authorised it on 19 February 2002.
Who is the marketing authorisation holder for Zevalin in Israel?
SPECTRUM PHARMS holds the Israeli marketing authorisation.